Compare Stocks: GMRS, PRVA, WGS, and ADUS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$118.01 -2.2%	$111.53	$87.95 ▼ $124.43	$2.25B	0.87	209,534 shs	208,390 shs
GMRS GMR Solutions	$12.57 -2.0%	$13.60	$10.26 ▼ $15.98	$692.56M	N/A	787,439 shs	362,080 shs
PRVA Privia Health Group	$20.86 -1.0%	$24.39	$19.53 ▼ $28.82	$2.69B	0.85	1.23 million shs	943,542 shs
WGS GeneDx	$89.24 -1.2%	$70.18	$32.21 ▼ $170.87	$2.69B	1.92	799,371 shs	354,295 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	-0.31%	+0.57%	+4.38%	+29.06%	+5.75%
GMRS GMR Solutions	+1.33%	-9.97%	+1.49%	+2.46%	+1,290,999,900.00%
PRVA Privia Health Group	-0.61%	-1.95%	-14.59%	-2.41%	-1.50%
WGS GeneDx	+3.31%	+13.36%	+49.14%	+80.04%	-28.48%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$118.01 -2.2%	$111.53	$87.95 ▼ $124.43	$2.25B	0.87	209,534 shs	208,390 shs
GMRS GMR Solutions	$12.57 -2.0%	$13.60	$10.26 ▼ $15.98	$692.56M	N/A	787,439 shs	362,080 shs
PRVA Privia Health Group	$20.86 -1.0%	$24.39	$19.53 ▼ $28.82	$2.69B	0.85	1.23 million shs	943,542 shs
WGS GeneDx	$89.24 -1.2%	$70.18	$32.21 ▼ $170.87	$2.69B	1.92	799,371 shs	354,295 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	-0.31%	+0.57%	+4.38%	+29.06%	+5.75%
GMRS GMR Solutions	+1.33%	-9.97%	+1.49%	+2.46%	+1,290,999,900.00%
PRVA Privia Health Group	-0.61%	-1.95%	-14.59%	-2.41%	-1.50%
WGS GeneDx	+3.31%	+13.36%	+49.14%	+80.04%	-28.48%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADUS Addus HomeCare	2.73	Moderate Buy	$130.88	10.90% Upside
GMRS GMR Solutions	2.70	Moderate Buy	$18.67	48.50% Upside
PRVA Privia Health Group	2.79	Moderate Buy	$31.00	48.61% Upside
WGS GeneDx	2.67	Moderate Buy	$89.57	0.37% Upside

Current Analyst Ratings Breakdown

Latest GMRS, PRVA, WGS, and ADUS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2026	GMRS GMR Solutions	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$30.00
8/14/2026	GMRS GMR Solutions	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (D)
8/7/2026	PRVA Privia Health Group	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$32.00
8/5/2026	ADUS Addus HomeCare	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$130.00 ➝ $134.00
8/5/2026	PRVA Privia Health Group	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/4/2026	WGS GeneDx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D)
8/4/2026	WGS GeneDx	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$75.00 ➝ $90.00
8/4/2026	WGS GeneDx	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$90.00
7/28/2026	WGS GeneDx	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/24/2026	ADUS Addus HomeCare	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform
7/23/2026	PRVA Privia Health Group	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 8/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADUS Addus HomeCare	$1.42B	1.55	$6.35 per share	18.59	$61.48 per share	1.92
GMRS GMR Solutions	N/A	N/A	N/A	N/A	$14.61 per share	N/A
PRVA Privia Health Group	$2.12B	1.26	$0.26 per share	78.95	$6.56 per share	3.18
WGS GeneDx	$454.43M	5.86	$2.27 per share	39.39	$8.19 per share	10.90

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADUS Addus HomeCare	$95.91M	$5.70	20.70	17.46	1.62	7.13%	9.96%	7.62%	11/2/2026 (Estimated)
GMRS GMR Solutions	N/A	-$1.56	N/A	8.11	0.29	N/A	N/A	N/A	N/A
PRVA Privia Health Group	$22.92M	$0.21	99.34	50.88	1.66	1.19%	3.52%	2.00%	11/5/2026 (Estimated)
WGS GeneDx	-$21.02M	-$3.64	N/A	77.60	N/A	-23.41%	4.12%	2.26%	10/27/2026 (Estimated)

Latest GMRS, PRVA, WGS, and ADUS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	GMRS GMR Solutions	$0.38	-$1.84	-$2.22	-$1.84	N/A	$1.49 billion
8/6/2026	Q2 2026	PRVA Privia Health Group	$0.0674	$0.19	+$0.1226	$0.07	$597.33 million	$632.63 million
8/3/2026	Q2 2026	ADUS Addus HomeCare	$1.70	$1.73	+$0.03	$1.49	$376.24 million	$377.41 million
8/3/2026	Q2 2026	WGS GeneDx	-$0.1879	$0.01	+$0.1979	-$0.60	$111.01 million	$114.44 million
6/1/2026	Q1 2026	GMRS GMR Solutions	N/A	$0.28	N/A	$0.28	N/A	$1.46 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADUS Addus HomeCare	N/A	N/A	N/A	N/A	N/A
GMRS GMR Solutions	N/A	N/A	N/A	N/A	N/A
PRVA Privia Health Group	N/A	N/A	N/A	N/A	N/A
WGS GeneDx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADUS Addus HomeCare	0.05	1.69	1.69
GMRS GMR Solutions	5.50	2.01	2.01
PRVA Privia Health Group	N/A	1.62	1.62
WGS GeneDx	0.40	3.30	3.06

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADUS Addus HomeCare	95.35%
GMRS GMR Solutions	N/A
PRVA Privia Health Group	94.48%
WGS GeneDx	61.72%

Insider Ownership

Company	Insider Ownership
ADUS Addus HomeCare	4.10%
GMRS GMR Solutions	N/A
PRVA Privia Health Group	5.70%
WGS GeneDx	25.17%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADUS Addus HomeCare	50,659	18.67 million	17.91 million	Optionable
GMRS GMR Solutions	N/A	54.02 million	N/A	N/A
PRVA Privia Health Group	1,226	127.73 million	120.45 million	Optionable
WGS GeneDx	1,300	29.82 million	22.32 million	Optionable

GMRS, PRVA, WGS, and ADUS Headlines

Recent News About These Companies

GeneDx Holdings Corp (WGS) Shares Surge 3.3% -- What GF Score of 65 Tells Investors

August 26 at 8:00 PM | gurufocus.com

Royal Bank of Canada Has $571,000 Stock Holdings in GeneDx Holdings Corp. $WGS

August 25 at 4:31 AM | marketbeat.com

GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s

August 24 at 7:38 PM | uk.finance.yahoo.com

GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children's

August 24 at 9:36 AM | markets.ft.com

GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of "Moderate Buy" from Brokerages

August 22, 2026 | americanbankingnews.com

GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of "Moderate Buy" from Analysts

August 22, 2026 | marketbeat.com

GeneDx Holdings Corp. $WGS Shares Purchased by Bank of America Corp DE

August 21, 2026 | marketbeat.com

Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?

August 19, 2026 | zacks.com

GeneDx: Why I Think The Worst Is Behind The Business

August 18, 2026 | seekingalpha.com

The Manufacturers Life Insurance Company Sells 12,820 Shares of GeneDx Holdings Corp. $WGS

August 14, 2026 | marketbeat.com

Sei Investments Co. Trims Stock Position in GeneDx Holdings Corp. $WGS

August 13, 2026 | marketbeat.com

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

August 12, 2026 | insurancenewsnet.comI

GeneDx (WGS) Q2 2026 Earnings Call Transcript

August 12, 2026 | finance.yahoo.com

Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Value Says Overvalued

August 11, 2026 | gurufocus.com

Assenagon Asset Management S.A. Acquires 208,305 Shares of GeneDx Holdings Corp. $WGS

August 10, 2026 | marketbeat.com

Piper Sandler Sticks to Its Buy Rating for GeneDx Holdings (WGS)

August 8, 2026 | theglobeandmail.com

GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From Blackstone

August 8, 2026 | finance.yahoo.com

GeneDx Holdings Corp. $WGS Shares Acquired by Dimensional Fund Advisors LP

August 8, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Hold Rating

August 8, 2026 | marketbeat.com

GeneDx to Participate in Upcoming Investor Conferences

August 6, 2026 | businesswire.com

GeneDx Holdings Corp. Earnings Call Highlights Risks

August 4, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMRS, PRVA, WGS, and ADUS Company Descriptions

Addus HomeCare NASDAQ:ADUS

$118.01 -2.70 (-2.24%)

Closing price 04:00 PM Eastern

Extended Trading

$118.03 +0.02 (+0.02%)

As of 07:30 PM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

GMR Solutions NYSE:GMRS

$12.57 -0.25 (-1.95%)

As of 03:58 PM Eastern

GMR Solutions Inc. is a provider of emergency medical services delivering EMS and other essential out-of-hospital care in rural and urban communities. GMR Solutions Inc. is based in Lewisville, Texas.

Privia Health Group NASDAQ:PRVA

$20.86 -0.21 (-1.00%)

Closing price 04:00 PM Eastern

Extended Trading

$21.05 +0.19 (+0.91%)

As of 07:30 PM Eastern

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

GeneDx NASDAQ:WGS

$89.24 -1.05 (-1.16%)

Closing price 04:00 PM Eastern

Extended Trading

$89.02 -0.22 (-0.25%)

As of 07:58 PM Eastern

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GMRS, PRVA, WGS, and ADUS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GMRS, PRVA, WGS, and ADUS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GMRS, PRVA, WGS, and ADUS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMRS, PRVA, WGS, and ADUS Company Descriptions

Addus HomeCare NASDAQ:ADUS

GMR Solutions NYSE:GMRS

Privia Health Group NASDAQ:PRVA

GeneDx NASDAQ:WGS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GMRS, PRVA, WGS, and ADUS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GMRS, PRVA, WGS, and ADUS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GMRS, PRVA, WGS, and ADUS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMRS, PRVA, WGS, and ADUS Company Descriptions

Addus HomeCare NASDAQ:ADUS

GMR Solutions NYSE:GMRS

Privia Health Group NASDAQ:PRVA

GeneDx NASDAQ:WGS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools